Aldose reductase inhibitors and diabetic complications.
D000449:Aldehyde Reductase / Q000037:antagonists & inhibitors* / Q000378:metabolism; D002386:Cataract / Q000188:drug therapy / Q000201:enzymology / Q000209:etiology; D002986:Clinical Trials as Topic; D048909:Diabetes Complications; D003920:Diabetes Mellitus / Q000188:drug therapy* / Q000201:enzymology; D003928:Diabetic Nephropathies / Q000188:drug therapy / Q000201:enzymology; D003929:Diabetic Neuropathies / Q000188:drug therapy / Q000201:enzymology; D003930:Diabetic Retinopathy / Q000188:drug therapy / Q000201:enzymology; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D013401:Sugar Alcohol Dehydrogenases / Q000037:antagonists & inhibitors*
D007004:Hypoglycemic Agents; D013401:Sugar Alcohol Dehydrogenases; D000449:Aldehyde Reductase